195 related articles for article (PubMed ID: 36728804)
1. Human DUX4 and porcine DUXC activate similar early embryonic programs in pig muscle cells: implications for preclinical models of FSHD.
Nip Y; Bennett SR; Smith AA; Jones TI; Jones PL; Tapscott SJ
Hum Mol Genet; 2023 May; 32(11):1864-1874. PubMed ID: 36728804
[TBL] [Abstract][Full Text] [Related]
2. Canine DUXC: implications for DUX4 retrotransposition and preclinical models of FSHD.
Wong CJ; Whiddon JL; Langford AT; Belleville AE; Tapscott SJ
Hum Mol Genet; 2022 May; 31(10):1694-1704. PubMed ID: 34888646
[TBL] [Abstract][Full Text] [Related]
3. Human DUX4 and mouse Dux interact with STAT1 and broadly inhibit interferon-stimulated gene induction.
Spens AE; Sutliff NA; Bennett SR; Campbell AE; Tapscott SJ
Elife; 2023 Apr; 12():. PubMed ID: 37092726
[TBL] [Abstract][Full Text] [Related]
4. p38
Rojas LA; Valentine E; Accorsi A; Maglio J; Shen N; Robertson A; Kazmirski S; Rahl P; Tawil R; Cadavid D; Thompson LA; Ronco L; Chang AN; Cacace AM; Wallace O
J Pharmacol Exp Ther; 2020 Sep; 374(3):489-498. PubMed ID: 32576599
[TBL] [Abstract][Full Text] [Related]
5. Transgenic mice expressing tunable levels of DUX4 develop characteristic facioscapulohumeral muscular dystrophy-like pathophysiology ranging in severity.
Jones TI; Chew GL; Barraza-Flores P; Schreier S; Ramirez M; Wuebbles RD; Burkin DJ; Bradley RK; Jones PL
Skelet Muscle; 2020 Apr; 10(1):8. PubMed ID: 32278354
[TBL] [Abstract][Full Text] [Related]
6. Facioscapulohumeral dystrophy: incomplete suppression of a retrotransposed gene.
Snider L; Geng LN; Lemmers RJ; Kyba M; Ware CB; Nelson AM; Tawil R; Filippova GN; van der Maarel SM; Tapscott SJ; Miller DG
PLoS Genet; 2010 Oct; 6(10):e1001181. PubMed ID: 21060811
[TBL] [Abstract][Full Text] [Related]
7. The DUX4-HIF1α Axis in Murine and Human Muscle Cells: A Link More Complex Than Expected.
Nguyen TH; Limpens M; Bouhmidi S; Paprzycki L; Legrand A; Declèves AE; Heher P; Belayew A; Banerji CRS; Zammit PS; Tassin A
Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542301
[TBL] [Abstract][Full Text] [Related]
8. Expression patterns of FSHD-causing DUX4 and myogenic transcription factors PAX3 and PAX7 are spatially distinct in differentiating human stem cell cultures.
Haynes P; Kernan K; Zhou SL; Miller DG
Skelet Muscle; 2017 Jun; 7(1):13. PubMed ID: 28637492
[TBL] [Abstract][Full Text] [Related]
9. Direct interplay between two candidate genes in FSHD muscular dystrophy.
Ferri G; Huichalaf CH; Caccia R; Gabellini D
Hum Mol Genet; 2015 Mar; 24(5):1256-66. PubMed ID: 25326393
[TBL] [Abstract][Full Text] [Related]
10. Influence of
Duranti E; Villa C
Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298453
[TBL] [Abstract][Full Text] [Related]
11. DUX4 Signalling in the Pathogenesis of Facioscapulohumeral Muscular Dystrophy.
Lim KRQ; Nguyen Q; Yokota T
Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 31979100
[TBL] [Abstract][Full Text] [Related]
12. DUX4 Role in Normal Physiology and in FSHD Muscular Dystrophy.
Mocciaro E; Runfola V; Ghezzi P; Pannese M; Gabellini D
Cells; 2021 Nov; 10(12):. PubMed ID: 34943834
[TBL] [Abstract][Full Text] [Related]
13. WDR5 is required for DUX4 expression and its pathological effects in FSHD muscular dystrophy.
Mocciaro E; Giambruno R; Micheloni S; Cernilogar FM; Andolfo A; Consonni C; Pannese M; Ferri G; Runfola V; Schotta G; Gabellini D
Nucleic Acids Res; 2023 Jun; 51(10):5144-5161. PubMed ID: 37021550
[TBL] [Abstract][Full Text] [Related]
14. DUX4-Induced Histone Variants H3.X and H3.Y Mark DUX4 Target Genes for Expression.
Resnick R; Wong CJ; Hamm DC; Bennett SR; Skene PJ; Hake SB; Henikoff S; van der Maarel SM; Tapscott SJ
Cell Rep; 2019 Nov; 29(7):1812-1820.e5. PubMed ID: 31722199
[TBL] [Abstract][Full Text] [Related]
15. Sporadic DUX4 expression in FSHD myocytes is associated with incomplete repression by the PRC2 complex and gain of H3K9 acetylation on the contracted D4Z4 allele.
Haynes P; Bomsztyk K; Miller DG
Epigenetics Chromatin; 2018 Aug; 11(1):47. PubMed ID: 30122154
[TBL] [Abstract][Full Text] [Related]
16. A patient-derived iPSC model revealed oxidative stress increases facioscapulohumeral muscular dystrophy-causative DUX4.
Sasaki-Honda M; Jonouchi T; Arai M; Hotta A; Mitsuhashi S; Nishino I; Matsuda R; Sakurai H
Hum Mol Genet; 2018 Dec; 27(23):4024-4035. PubMed ID: 30107443
[TBL] [Abstract][Full Text] [Related]
17. p53 convergently activates Dux/DUX4 in embryonic stem cells and in facioscapulohumeral muscular dystrophy cell models.
Grow EJ; Weaver BD; Smith CM; Guo J; Stein P; Shadle SC; Hendrickson PG; Johnson NE; Butterfield RJ; Menafra R; Kloet SL; van der Maarel SM; Williams CJ; Cairns BR
Nat Genet; 2021 Aug; 53(8):1207-1220. PubMed ID: 34267371
[TBL] [Abstract][Full Text] [Related]
18. Facioscapulohumeral muscular dystrophy family studies of DUX4 expression: evidence for disease modifiers and a quantitative model of pathogenesis.
Jones TI; Chen JC; Rahimov F; Homma S; Arashiro P; Beermann ML; King OD; Miller JB; Kunkel LM; Emerson CP; Wagner KR; Jones PL
Hum Mol Genet; 2012 Oct; 21(20):4419-30. PubMed ID: 22798623
[TBL] [Abstract][Full Text] [Related]
19. Conservation and innovation in the DUX4-family gene network.
Whiddon JL; Langford AT; Wong CJ; Zhong JW; Tapscott SJ
Nat Genet; 2017 Jun; 49(6):935-940. PubMed ID: 28459454
[TBL] [Abstract][Full Text] [Related]
20. DUX4 expression in FSHD muscle cells: how could such a rare protein cause a myopathy?
Tassin A; Laoudj-Chenivesse D; Vanderplanck C; Barro M; Charron S; Ansseau E; Chen YW; Mercier J; Coppée F; Belayew A
J Cell Mol Med; 2013 Jan; 17(1):76-89. PubMed ID: 23206257
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
